Go Pro

RH (RH) Financials

RH logo
$133.91 -0.11 (-0.08%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$133.83 -0.08 (-0.06%)
As of 09/11/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for RH

Annual Income Statements for RH

This table shows RH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2023 2024 2025
Period end date 1/31/2015 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025
Net Income / (Loss) Attributable to Common Shareholders
91 91 5.40 -2.60 136 220 272 689 529 128 72
Consolidated Net Income / (Loss)
91 91 5.40 -2.60 136 220 272 689 529 128 72
Net Income / (Loss) Continuing Operations
91 91 5.40 -2.60 136 220 272 689 529 128 72
Total Pre-Tax Income
148 150 8.55 23 161 269 377 830 439 167 89
Total Operating Income
166 186 53 117 262 363 467 927 722 366 323
Total Gross Profit
691 753 680 839 986 1,095 1,326 1,855 1,812 1,389 1,415
Total Revenue
1,867 2,109 2,135 2,440 2,506 2,647 2,849 3,759 3,590 3,029 3,181
Operating Revenue
1,867 2,109 2,135 2,440 2,506 2,647 2,849 3,759 3,590 3,029 3,181
Total Cost of Revenue
1,177 1,356 1,455 1,601 1,520 1,552 1,523 1,903 1,778 1,640 1,766
Operating Cost of Revenue
1,177 1,356 1,455 1,601 1,520 1,552 1,523 1,903 1,778 1,640 1,766
Total Operating Expenses
525 567 627 722 724 732 859 928 1,090 1,023 1,092
Selling, General & Admin Expense
525 567 627 722 724 732 859 928 1,090 1,023 1,092
Total Other Income / (Expense), net
-18 -36 -44 -95 -101 -94 -90 -97 -283 -199 -234
Interest & Investment Income
- - - - - - - - -113 -198 -231
Other Income / (Expense), net
- - - -34 -32 -6.47 -20 -2.78 -0.03 -1.08 -3.40
Income Tax Expense
57 59 3.15 25 25 49 105 134 -91 28 4.80
Other Gains / (Losses), net
- - - - 0.00 0.00 -0.89 -8.21 -2.06 -11 -11
Basic Earnings per Share
$2.31 $2.27 $0.13 ($0.10) $6.28 $11.55 $13.82 $32.37 $22.47 $6.42 $3.92
Weighted Average Basic Shares Outstanding
39.46M 40.19M 40.69M 27.05M 21.61M 19.08M 19.67M 21.27M 23.52M 19.88M 18.49M
Diluted Earnings per Share
$2.20 $2.16 $0.13 ($0.10) $5.12 $9.07 $9.96 $22.13 $19.90 $5.91 $3.62
Weighted Average Diluted Shares Outstanding
41.38M 42.26M 40.93M 27.05M 26.53M 24.30M 27.30M 31.11M 26.56M 21.60M 19.99M
Weighted Average Basic & Diluted Shares Outstanding
39.40M 40.10M 41.50M 27.30M 21.60M 19.24M 21.00M 21.71M 22.05M 18.32M 18.83M

Quarterly Income Statements for RH

This table shows RH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 4/29/2023 7/29/2023 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/1/2026 11/1/2025
Net Income / (Loss) Attributable to Common Shareholders
42 76 -2.19 69 -3.63 29 33 14 8.04 60 36
Consolidated Net Income / (Loss)
42 76 -2.19 69 -3.63 29 33 14 8.04 60 36
Net Income / (Loss) Continuing Operations
42 76 -2.19 69 -3.63 29 33 14 8.04 60 36
Total Pre-Tax Income
60 107 -8.71 89 -3.27 38 44 10 2.96 58 48
Total Operating Income
99 151 51 114 55 96 101 70 56 108 106
Total Gross Profit
348 380 340 337 316 375 361 363 355 445 390
Total Revenue
739 800 751 661 727 830 812 812 814 922 884
Operating Revenue
739 800 751 661 727 830 812 812 814 922 884
Total Cost of Revenue
392 420 411 324 411 455 450 450 459 477 494
Operating Cost of Revenue
392 420 411 324 411 455 450 450 459 477 494
Total Operating Expenses
248 229 289 223 261 279 260 292 299 337 284
Selling, General & Admin Expense
248 229 289 223 261 279 260 292 299 337 284
Total Other Income / (Expense), net
-39 -44 -60 -25 -58 -59 -58 -60 -53 -49 -58
Interest & Investment Income
- - - - -57 -59 -58 - -57 -51 -57
Other Income / (Expense), net
0.65 0.19 -5.31 -0.55 -1.17 0.66 -0.03 -2.87 3.65 1.86 -0.69
Income Tax Expense
17 27 -9.22 17 -2.09 3.72 9.26 -6.08 3.13 16 12
Other Gains / (Losses), net
-1.60 -3.38 -2.69 -2.15 -2.44 -4.86 -1.43 -2.65 8.21 18 -0.19
Basic Earnings per Share
$1.90 $3.65 ($0.12) $3.26 ($0.20) $1.57 $1.79 $0.76 $0.43 $3.18 $1.93
Weighted Average Basic Shares Outstanding
22.05M 20.96M 18.37M 19.88M 18.32M 18.46M 18.53M 18.49M 18.73M 18.91M 18.76M
Diluted Earnings per Share
$1.76 $3.36 ($0.12) $3.00 ($0.20) $1.45 $1.66 $0.71 $0.40 $3.06 $1.83
Weighted Average Diluted Shares Outstanding
23.76M 22.73M 18.37M 21.60M 18.32M 19.96M 19.98M 19.99M 19.91M 19.67M 19.81M
Weighted Average Basic & Diluted Shares Outstanding
22.05M 18.40M 18.22M 18.32M 18.45M 18.75M 18.78M 18.73M 18.90M 18.93M 18.78M

Annual Cash Flow Statements for RH

This table details how cash moves in and out of RH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2023 2024 2025
Period end date 1/31/2015 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 1/31/2026
Net Change in Cash & Equivalents
132 186 -232 -90 -20 366 59 2,075 -670 -1,388 11
Net Cash From Operating Activities
79 127 81 475 250 339 501 662 404 202 452
Net Cash From Continuing Operating Activities
79 127 81 474 250 339 501 662 404 202 452
Net Income / (Loss) Continuing Operations
91 91 5.40 -2.60 136 220 272 689 529 128 125
Consolidated Net Income / (Loss)
91 91 5.40 -2.60 136 220 272 689 529 128 125
Depreciation Expense
34 45 57 83 91 101 100 96 109 119 149
Non-Cash Adjustments To Reconcile Net Income
1.99 16 64 119 109 -4.22 129 66 306 161 113
Changes in Operating Assets and Liabilities, net
-56 -49 -76 245 -129 -24 -42 -217 -539 -205 65
Net Cash From Investing Activities
-201 -227 -311 123 -80 -123 -198 -194 -171 -307 -224
Net Cash From Continuing Investing Activities
-201 -227 -311 123 -80 -123 -198 -194 -171 -307 -224
Purchase of Property, Plant & Equipment
-110 -133 -170 -68 -80 -94 -111 -185 -174 -269 -200
Acquisitions
-0.45 -0.34 -116 - 0.00 0.00 -99 -8.97 -2.71 -38 -36
Sale and/or Maturity of Investments
11 144 224 192 - - - - - 0.00 7.92
Other Investing Activities, net
-9.25 -20 - - 0.00 -53 -13 - - 0.00 3.83
Net Cash From Financing Activities
254 287 -2.24 -687 -189 -175 -244 1,607 -902 -1,283 -219
Net Cash From Continuing Financing Activities
254 287 -2.24 -687 -189 149 -244 1,607 -902 -1,281 -219
Repayment of Debt
-845 -2.63 -0.61 -514 -1,127 -685 -263 -390 20 -27 -536
Repurchase of Common Equity
- - 0.00 -1,000 -250 -250 0.00 0.00 -1,391 -1,253 0.00
Issuance of Debt
1,100 296 0.00 814 1,202 1,115 13 2,000 16 0.00 325
Other Financing Activities, net
-42 -37 -1.63 13 -64 -81 6.03 -2.78 452 -1.85 -8.65
Other Net Changes in Cash
- - - - - - - - - - 1.63
Cash Interest Paid
8.61 13 17 28 31 43 27 39 134 246 217
Cash Income Taxes Paid
60 29 48 4.03 41 40 74 159 41 28 13

Quarterly Cash Flow Statements for RH

This table details how cash moves in and out of RH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 1/28/2023 4/29/2023 8/3/2024 11/2/2024 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/2/2026 8/2/2025
Net Change in Cash & Equivalents
459 8.46 -23 8.68 -1,351 -22 -23 8.68 -57 13 -12
Net Cash From Operating Activities
88 87 11 -31 166 56 11 -31 -19 53 138
Net Cash From Continuing Operating Activities
88 87 11 -31 166 56 11 -31 -19 53 138
Net Income / (Loss) Continuing Operations
412 42 29 33 69 -3.63 29 33 14 -14 52
Consolidated Net Income / (Loss)
412 42 29 33 69 -3.63 29 33 14 -14 52
Depreciation Expense
24 28 32 33 23 31 32 33 34 39 35
Non-Cash Adjustments To Reconcile Net Income
187 35 43 51 29 38 43 51 47 15 25
Changes in Operating Assets and Liabilities, net
-536 -18 -93 -149 45 -9.28 -93 -149 -114 13 26
Net Cash From Investing Activities
-4.91 -67 -56 -65 -118 -69 -56 -65 -51 -39 -89
Net Cash From Continuing Investing Activities
-4.91 -67 -56 -65 -118 -69 -56 -65 -51 -39 -89
Purchase of Property, Plant & Equipment
-42 -34 -49 -65 -89 -66 -49 -65 -51 -39 -57
Acquisitions
32 -33 -6.74 -0.20 -28 -2.68 -6.74 -0.20 -0.00 0.00 -32
Other Investing Activities, net
- - - - - 0.00 - - - 0.00 0.28
Net Cash From Financing Activities
376 -11 21 105 -1,400 -8.92 21 105 14 -0.58 -60
Net Cash From Continuing Financing Activities
376 -11 21 105 -1,400 -8.92 21 105 14 -0.58 -60
Repayment of Debt
42 -7.42 -1.76 -48 33 -6.26 -6.26 -48 -41 -101 -134
Issuance of Debt
16 - - 165 -190 0.00 25 165 45 105 75
Other Financing Activities, net
456 -3.52 -2.46 0.07 -1.69 -2.66 2.04 0.07 10 -4.23 -1.14
Effect of Exchange Rate Changes
- -0.02 - - - -0.17 0.41 - -0.76 -0.09 0.14

Annual Balance Sheets for RH

This table presents RH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2023 2024 2025
Period end date 1/31/2015 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 1/31/2026
Total Assets
1,526 2,068 2,193 1,733 2,423 2,446 2,898 5,540 5,309 4,144 4,836
Total Current Assets
884 1,295 1,138 645 704 597 801 3,091 2,513 1,102 1,108
Cash & Equivalents
149 331 87 18 5.80 48 100 2,178 1,508 124 41
Accounts Receivable
26 29 34 31 40 49 59 58 60 55 63
Inventories, net
559 725 752 527 532 439 544 734 802 754 819
Prepaid Expenses
88 79 117 69 104 62 97 121 139 169 184
Plant, Property, & Equipment, net
391 516 682 801 953 968 1,077 1,228 1,636 1,686 2,159
Total Noncurrent Assets
251 257 372 287 766 881 1,020 1,221 1,161 1,356 1,569
Long-Term Investments
18 22 33 - - 0.00 101 101 101 129 120
Goodwill
124 124 174 142 124 124 141 141 141 141 224
Noncurrent Deferred & Refundable Income Taxes
37 37 28 23 36 45 50 57 167 144 128
Other Noncurrent Operating Assets
23 25 36 21 520 626 656 849 676 867 1,097
Total Liabilities & Shareholders' Equity
1,526 2,068 2,193 1,733 2,423 2,446 2,898 5,540 5,309 4,144 4,836
Total Liabilities
823 1,182 1,273 1,740 2,462 2,427 2,451 4,370 4,525 4,441 4,775
Total Current Liabilities
344 434 416 519 993 983 922 1,064 886 873 931
Accounts Payable
235 262 227 319 320 330 424 442 375 367 387
Current Deferred Revenue
74 107 146 149 153 162 281 388 326 283 339
Other Current Liabilities
36 65 43 51 176 200 214 220 184 182 205
Total Noncurrent Liabilities
194 748 856 1,221 1,469 1,444 1,530 3,306 3,639 3,568 3,845
Long-Term Debt
29 547 593 937 610 563 564 2,197 2,465 2,406 2,389
Noncurrent Deferred & Payable Income Tax Liabilities
0.13 - - - - - - 0.00 6.32 8.44 18
Other Noncurrent Operating Liabilities
125 147 203 229 859 881 965 1,110 1,167 1,154 1,438
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
703 886 920 -7.34 -39 19 447 1,170 785 -297 61
Total Preferred & Common Equity
703 886 920 -7.34 -39 19 447 1,170 785 -297 61
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
703 886 920 -7.34 -39 19 447 1,170 785 -297 61
Common Stock
669 764 791 841 356 431 582 621 247 288 410
Retained Earnings
54 145 150 152 -393 -409 -137 551 540 -583 -386
Accumulated Other Comprehensive Income / (Loss)
-0.50 -2.70 -1.69 -0.17 -2.33 -2.76 2.57 -1.41 -2.40 -1.94 36

Quarterly Balance Sheets for RH

This table presents RH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 7/29/2023 10/28/2023 4/29/2023 7/29/2023 10/28/2023 5/4/2024 8/3/2024 11/2/2024 5/2/2026 8/1/2026 11/1/2025
Total Assets
4,213 4,241 5,320 4,213 4,241 4,187 4,376 4,464 4,948 5,131 4,794
Total Current Assets
1,357 1,287 2,476 1,357 1,287 1,116 1,219 1,278 1,124 1,159 1,124
Cash & Equivalents
417 381 1,517 417 381 102 78 87 54 125 43
Accounts Receivable
54 56 60 54 56 63 67 63 72 79 63
Inventories, net
738 719 766 738 719 802 917 979 802 773 875
Prepaid Expenses
144 129 129 144 129 149 157 149 195 182 143
Plant, Property, & Equipment, net
1,655 1,665 1,641 1,655 1,665 1,693 1,754 1,797 2,220 2,594 2,175
Total Noncurrent Assets
1,201 1,288 1,203 1,201 1,288 1,377 1,403 1,389 1,604 1,378 1,494
Long-Term Investments
130 128 133 130 128 129 131 130 119 69 121
Goodwill
141 141 141 141 141 141 141 141 224 224 144
Intangible Assets
75 76 75 75 76 76 76 76 - - 80
Noncurrent Deferred & Refundable Income Taxes
123 126 151 123 126 144 144 139 128 128 148
Other Noncurrent Operating Assets
731 817 704 731 817 887 911 904 1,132 956 1,001
Total Liabilities & Shareholders' Equity
4,213 4,241 5,320 4,213 4,241 4,187 4,376 4,464 4,948 5,131 4,794
Total Liabilities
4,497 4,574 4,480 4,497 4,574 4,476 4,611 4,647 4,891 5,011 4,790
Total Current Liabilities
873 935 852 873 935 936 1,011 896 997 1,033 946
Accounts Payable
357 400 322 357 400 407 496 412 412 423 377
Current Deferred Revenue
331 303 345 331 303 316 303 308 382 402 349
Other Current Liabilities
184 190 183 184 190 171 170 177 203 208 221
Total Noncurrent Liabilities
3,625 3,639 3,629 3,625 3,639 3,540 3,601 3,751 3,894 3,978 3,844
Long-Term Debt
2,457 2,411 2,461 2,457 2,411 2,402 2,422 2,583 2,394 2,360 2,438
Noncurrent Deferred & Payable Income Tax Liabilities
6.40 6.14 6.40 6.40 6.14 8.42 8.54 8.50 18 17 11
Other Noncurrent Operating Liabilities
1,162 1,222 1,161 1,162 1,222 1,130 1,170 1,159 1,482 1,600 1,394
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-285 -333 839 -285 -333 -290 -235 -183 57 120 3.35
Total Preferred & Common Equity
-285 -333 839 -285 -333 -290 -235 -183 57 120 3.35
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-285 -333 839 -285 -333 -290 -235 -183 57 120 3.35
Common Stock
262 271 258 262 271 300 321 341 425 439 400
Retained Earnings
-550 -595 582 -550 -595 -587 -558 -525 -400 -340 -415
Accumulated Other Comprehensive Income / (Loss)
3.27 -9.00 -0.11 3.27 -9.00 -3.22 2.00 1.14 32 21 18

Annual Metrics And Ratios for RH

This table displays calculated financial ratios and metrics derived from RH's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2023 2024 2025
Period end date 1/31/2015 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
20.40% 12.94% 1.23% 14.30% 2.68% 5.66% 7.60% 31.95% 0.00% -15.63% 5.01%
EBITDA Growth
152.30% 21.75% -44.81% 40.80% 84.26% 38.70% 17.01% 78.15% 0.00% -40.39% -7.15%
EBIT Growth
202.14% 11.97% -71.42% 57.28% 175.31% 55.17% 25.31% 107.01% 0.00% -49.46% -12.55%
NOPAT Growth
400.92% 10.81% -70.31% -140.34% 1,733.86% 34.59% 13.60% 130.58% 0.00% -65.15% 0.36%
Net Income Growth
400.15% 0.11% -94.07% -148.12% 5,322.43% 62.36% 23.34% 153.31% 0.00% -75.87% -43.23%
EPS Growth
388.89% -1.82% -93.98% -176.92% 5,220.00% 77.15% 9.81% 122.19% 0.00% -70.30% -38.75%
Operating Cash Flow Growth
-9.46% 59.89% -36.46% 489.36% -47.40% 35.89% 47.64% 32.22% 0.00% -95.77% -91.55%
Free Cash Flow Firm Growth
4.93% 27.21% -442.89% 221.51% -31.60% 71.96% 4.19% 10.43% 0.00% 0.00% -241.08%
Invested Capital Growth
27.46% 20.60% 31.73% -27.09% -0.19% -9.39% -7.40% 44.29% 0.00% 15.86% 19.35%
Revenue Q/Q Growth
6.32% 3.15% -2.76% 3.55% 0.02% -0.22% 5.46% 2.46% 0.00% -17.42% 2.39%
EBITDA Q/Q Growth
14.78% -0.06% -20.75% 5.21% 0.39% 0.77% 10.66% 2.81% 0.00% -37.85% -0.16%
EBIT Q/Q Growth
11.48% -4.18% -43.07% -6.58% 1.11% 1.41% 16.22% 3.51% 0.00% -46.05% -0.06%
NOPAT Q/Q Growth
23.51% -4.99% -39.80% -135.92% 25.01% 6.94% 17.77% 5.25% 0.00% -65.77% 1.73%
Net Income Q/Q Growth
21.14% -9.19% -81.55% -122.89% 30.56% 22.98% 29.40% 2.51% 0.00% -72.91% 3.63%
EPS Q/Q Growth
18.92% -10.00% -81.16% -123.81% 36.90% 20.13% 27.86% 0.87% 0.00% -66.82% -5.24%
Operating Cash Flow Q/Q Growth
130.98% 50.17% -35.77% -3.08% 37.80% -6.79% 5.32% -3.65% 0.00% -86.14% 121.89%
Free Cash Flow Firm Q/Q Growth
4.46% 55.38% -40.56% 25.46% -70.03% 198.13% 418.85% -24.74% 100.00% -85.92% 77.38%
Invested Capital Q/Q Growth
3.22% -4.29% 1.01% -10.29% 101.98% 37.41% -5.72% 14.22% 1.87% -13.05% 3.77%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
36.99% 35.69% 31.84% 34.40% 39.33% 41.36% 46.53% 49.36% 50.47% 45.86% 44.48%
EBITDA Margin
11.15% 12.02% 6.55% 8.07% 14.48% 19.01% 20.68% 27.91% 23.14% 16.35% 14.13%
Operating Margin
8.87% 8.80% 2.48% 4.80% 10.45% 13.71% 16.39% 24.67% 20.11% 12.09% 10.14%
EBIT Margin
8.87% 8.80% 2.48% 3.42% 9.17% 13.46% 15.68% 24.59% 20.11% 12.05% 10.04%
Profit (Net Income) Margin
4.87% 4.32% 0.25% -0.11% 5.42% 8.32% 9.54% 18.32% 14.72% 4.21% 2.28%
Tax Burden Percent
61.42% 60.78% 63.14% -11.53% 84.32% 81.87% 72.04% 82.93% 120.33% 76.52% 81.74%
Interest Burden Percent
89.41% 80.77% 16.13% 27.01% 70.09% 75.54% 84.49% 89.82% 60.84% 45.67% 27.75%
Effective Tax Rate
38.58% 39.22% 36.86% 111.53% 15.68% 18.13% 27.72% 16.09% -20.79% 16.95% 5.42%
Return on Invested Capital (ROIC)
14.50% 13.00% 3.05% -1.25% 24.24% 34.26% 42.51% 83.46% 53.24% 17.19% 14.65%
ROIC Less NNEP Spread (ROIC-NNEP)
0.67% -16.58% -11.25% 0.50% 15.14% 25.52% 30.81% 11.03% 12.99% 5.62% 4.59%
Return on Net Nonoperating Assets (RNNOA)
0.08% -1.53% -2.45% 0.68% -614.04% -2,233.73% 74.23% 1.69% 14.13% 35.17% -46.07%
Return on Equity (ROE)
14.58% 11.47% 0.60% -0.57% -589.80% -2,199.46% 116.74% 85.15% 67.37% 52.36% -31.42%
Cash Return on Invested Capital (CROIC)
-9.65% -5.68% -24.34% 30.09% 24.43% 44.12% 50.20% 47.20% 0.00% 2.49% -2.99%
Operating Return on Assets (OROA)
12.99% 10.33% 2.49% 4.25% 11.05% 14.64% 16.71% 21.91% 13.60% 7.72% 7.34%
Return on Assets (ROA)
7.13% 5.07% 0.25% -0.13% 6.53% 9.05% 10.17% 16.32% 9.96% 2.70% 1.66%
Return on Common Equity (ROCE)
14.58% 11.47% 0.60% -0.57% -589.80% -2,199.46% 116.74% 85.15% 67.37% 52.36% -31.42%
Return on Equity Simple (ROE_SIMPLE)
0.00% 10.28% 0.59% 35.43% -350.82% 1,181.57% 60.81% 58.84% 67.37% -42.89% 0.00%
Net Operating Profit after Tax (NOPAT)
102 113 33 -14 221 297 337 778 872 304 305
NOPAT Margin
5.45% 5.35% 1.57% -0.55% 8.81% 11.22% 11.85% 20.70% 24.30% 10.04% 9.59%
Net Nonoperating Expense Percent (NNEP)
13.83% 29.58% 14.30% -1.75% 9.10% 8.74% 11.70% 72.43% 40.25% 11.57% 10.06%
Return On Investment Capital (ROIC_SIMPLE)
13.91% - - - - - - - 26.83% 14.13% 12.59%
Cost of Revenue to Revenue
63.01% 64.31% 68.16% 65.61% 60.67% 58.64% 53.47% 50.64% 49.53% 54.14% 55.52%
SG&A Expenses to Revenue
28.12% 26.89% 29.36% 29.60% 28.89% 27.66% 30.14% 24.69% 30.35% 33.77% 34.34%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
28.12% 26.89% 29.36% 29.60% 28.89% 27.66% 30.14% 24.69% 30.35% 33.77% 34.34%
Earnings before Interest and Taxes (EBIT)
166 186 53 83 230 356 447 924 722 365 319
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
208 253 140 197 363 503 589 1,049 831 495 449
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.93 2.81 1.16 0.00 0.00 212.62 21.69 7.19 9.35 0.00 0.00
Price to Tangible Book Value (P/TBV)
6.54 3.50 1.65 0.00 0.00 0.00 41.40 8.80 12.89 0.00 0.00
Price to Revenue (P/Rev)
1.86 1.18 0.50 0.80 1.13 1.50 3.40 2.24 2.04 1.54 2.45
Price to Earnings (P/E)
38.07 27.38 197.10 0.00 20.89 17.99 35.68 12.22 13.88 36.57 107.67
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.63% 3.65% 0.51% 0.00% 4.79% 5.56% 2.80% 8.18% 7.21% 2.73% 0.93%
Enterprise Value to Invested Capital (EV/IC)
4.15 2.69 1.12 3.16 4.16 5.79 13.19 7.58 5.00 3.61 4.51
Enterprise Value to Revenue (EV/Rev)
1.75 1.21 0.65 1.18 1.51 1.80 3.53 2.22 2.28 2.26 3.22
Enterprise Value to EBITDA (EV/EBITDA)
15.68 10.09 9.97 14.62 10.43 9.48 17.09 7.95 9.86 13.85 22.76
Enterprise Value to EBIT (EV/EBIT)
19.69 13.78 26.30 34.53 16.48 13.39 22.54 9.03 11.34 18.80 32.04
Enterprise Value to NOPAT (EV/NOPAT)
32.07 22.67 41.65 0.00 17.14 16.06 29.82 10.73 9.39 22.57 33.52
Enterprise Value to Operating Cash Flow (EV/OCF)
41.19 20.18 17.32 6.07 15.16 14.07 20.10 12.60 20.29 401.32 598.19
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 8.86 17.01 12.48 25.26 18.97 0.00 155.53 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.04 0.62 0.64 -127.67 -24.66 45.75 1.27 1.89 3.14 -8.23 -15.81
Long-Term Debt to Equity
0.04 0.62 0.64 -127.67 -15.77 30.17 1.26 1.88 3.14 -8.09 -15.81
Financial Leverage
0.12 0.09 0.22 1.37 -40.56 -87.52 2.41 0.15 1.09 6.26 -10.03
Leverage Ratio
2.04 2.26 2.36 4.30 -90.29 -242.96 11.48 5.22 6.77 19.40 -18.87
Compound Leverage Factor
1.83 1.83 0.38 1.16 -63.29 -183.53 9.70 4.69 4.12 8.86 -5.24
Debt to Total Capital
3.95% 38.17% 39.20% 100.79% 104.23% 97.86% 55.91% 65.38% 75.87% 113.83% 106.75%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 37.56% 33.32% 0.23% 0.38% 0.05% 1.95% 0.00%
Long-Term Debt to Total Capital
3.95% 38.17% 39.20% 100.79% 66.67% 64.54% 55.67% 64.99% 75.82% 111.88% 106.75%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
96.05% 61.83% 60.80% -0.79% -4.23% 2.14% 44.09% 34.62% 24.13% -13.83% -6.75%
Debt to EBITDA
0.14 2.16 4.24 4.76 2.63 1.70 0.96 2.11 2.97 4.94 5.76
Net Debt to EBITDA
-0.96 0.25 2.36 4.66 2.61 1.60 0.62 -0.07 1.03 4.43 5.41
Long-Term Debt to EBITDA
0.14 2.16 4.24 4.76 1.68 1.12 0.96 2.09 2.97 4.86 5.76
Debt to NOPAT
0.28 4.85 17.71 -69.33 4.32 2.87 1.68 2.84 2.83 8.05 8.48
Net Debt to NOPAT
-1.97 0.56 9.86 -68.01 4.30 2.71 1.08 -0.09 0.98 7.22 7.96
Long-Term Debt to NOPAT
0.28 4.85 17.71 -69.33 2.77 1.89 1.67 2.82 2.83 7.92 8.48
Altman Z-Score
4.58 3.18 2.05 2.45 1.67 2.12 3.75 2.96 2.61 1.52 1.87
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.57 2.98 2.74 1.24 0.71 0.61 0.87 2.91 2.84 1.26 1.43
Quick Ratio
0.69 1.13 0.63 0.10 0.05 0.10 0.17 2.10 1.77 0.20 0.10
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-68 -49 -268 325 222 382 398 440 0.00 44 -62
Operating Cash Flow to CapEx
71.80% 94.94% 47.35% 890.75% 312.04% 487.72% 581.48% 357.16% 239.78% 7.41% 7.41%
Free Cash Flow to Firm to Interest Expense
-3.86 -1.38 -6.02 5.34 3.24 4.39 5.75 4.68 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
4.52 3.55 1.81 7.79 3.63 3.89 7.23 7.04 2.38 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-1.77 -0.19 -2.01 6.92 2.47 3.09 5.99 5.07 1.39 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.46 1.17 1.00 1.24 1.21 1.09 1.07 0.89 0.68 0.64 0.73
Accounts Receivable Turnover
77.82 77.35 68.04 74.39 69.96 59.36 52.53 64.04 60.08 52.76 53.66
Inventory Turnover
2.32 2.11 1.97 2.50 2.87 3.20 3.10 2.98 2.22 2.11 1.99
Fixed Asset Turnover
6.17 4.65 3.57 3.29 2.86 2.76 2.79 3.26 2.19 1.82 1.78
Accounts Payable Turnover
5.33 5.45 5.95 5.87 4.76 4.77 4.04 4.39 4.74 4.42 4.53
Days Sales Outstanding (DSO)
4.69 4.72 5.36 4.91 5.22 6.15 6.95 5.70 6.08 6.92 6.80
Days Inventory Outstanding (DIO)
157.14 172.86 185.34 145.84 127.14 114.11 117.78 122.58 164.56 173.14 183.32
Days Payable Outstanding (DPO)
68.55 66.93 61.36 62.22 76.75 76.51 90.43 83.11 76.95 82.51 80.61
Cash Conversion Cycle (CCC)
93.29 110.65 129.34 88.54 55.61 43.75 34.29 45.18 93.69 97.54 109.50
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
787 949 1,250 911 910 824 763 1,101 1,639 1,898 2,266
Invested Capital Turnover
2.66 2.43 1.94 2.26 2.75 3.05 3.59 4.03 2.19 1.71 1.53
Increase / (Decrease) in Invested Capital
170 162 301 -339 -1.70 -85 -61 338 0.00 260 367
Enterprise Value (EV)
3,264 2,557 1,395 2,880 3,784 4,771 10,064 8,345 8,189 6,861 10,226
Market Capitalization
3,464 2,494 1,065 1,961 2,835 3,966 9,698 8,414 7,335 4,665 7,797
Book Value per Share
$17.76 $21.89 $22.54 ($0.34) ($1.82) $0.98 $21.91 $54.51 $33.23 ($16.32) ($8.79)
Tangible Book Value per Share
$13.39 $17.62 $15.82 ($11.73) ($11.74) ($10.09) $11.48 $44.53 $24.10 ($28.23) ($20.46)
Total Capital
732 1,433 1,513 929 915 872 1,014 3,380 3,252 2,151 2,423
Total Debt
29 547 593 937 954 853 567 2,210 2,467 2,448 2,587
Total Long-Term Debt
29 547 593 937 610 563 564 2,197 2,465 2,406 2,587
Net Debt
-200 63 330 919 948 806 366 -69 854 2,196 2,429
Capital Expenditures (CapEx)
110 133 170 53 80 70 86 185 168 231 231
Debt-free, Cash-free Net Working Capital (DFCFNWC)
329 399 492 108 49 -143 -218 -137 117 147 356
Debt-free Net Working Capital (DFNWC)
540 861 722 126 55 -95 -118 2,041 1,628 271 386
Net Working Capital (NWC)
540 861 722 126 -289 -386 -120 2,028 1,627 229 386
Net Nonoperating Expense (NNE)
11 22 28 -11 85 77 66 89 344 176 233
Net Nonoperating Obligations (NNO)
84 63 330 919 948 806 316 -69 854 2,196 2,429
Total Depreciation and Amortization (D&A)
42 68 87 114 133 147 142 125 109 130 130
Debt-free, Cash-free Net Working Capital to Revenue
17.61% 18.91% 23.06% 4.41% 1.97% -5.40% -7.66% -3.65% 3.25% 4.86% 11.19%
Debt-free Net Working Capital to Revenue
28.92% 40.83% 33.82% 5.15% 2.20% -3.60% -4.14% 54.29% 45.35% 8.94% 12.14%
Net Working Capital to Revenue
28.92% 40.83% 33.82% 5.15% -11.52% -14.58% -4.22% 53.94% 45.31% 7.56% 12.14%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.31 $2.27 $0.13 $0.08 $6.97 $11.55 $13.82 $32.37 $22.47 $6.42 $3.92
Adjusted Weighted Average Basic Shares Outstanding
39.46M 40.19M 40.69M 27.05M 21.61M 19.08M 19.67M 21.27M 23.52M 19.88M 18.49M
Adjusted Diluted Earnings per Share
$2.20 $2.16 $0.13 $0.07 $5.68 $9.07 $9.96 $22.13 $19.90 $5.91 $3.62
Adjusted Weighted Average Diluted Shares Outstanding
41.38M 42.26M 40.93M 29.25M 26.53M 24.30M 27.30M 31.11M 26.56M 21.60M 19.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $6.97 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
39.89M 40.58M 35.90M 21.52M 20.48M 19.24M 21.00M 21.71M 22.05M 18.32M 18.73M
Normalized Net Operating Profit after Tax (NOPAT)
102 113 33 82 221 297 337 778 506 304 305
Normalized NOPAT Margin
5.45% 5.35% 1.57% 3.36% 8.81% 11.22% 11.85% 20.70% 14.08% 10.04% 9.59%
Pre Tax Income Margin
7.93% 7.11% 0.40% 0.92% 6.42% 10.17% 13.25% 22.09% 12.24% 5.50% 2.79%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
9.44 5.20 1.19 1.37 3.34 4.09 6.45 9.83 4.26 0.00 0.00
NOPAT to Interest Expense
5.80 3.16 0.75 -0.22 3.21 3.41 4.87 8.27 5.14 0.00 0.00
EBIT Less CapEx to Interest Expense
3.15 1.46 -2.63 0.50 2.18 3.29 5.20 7.85 3.27 0.00 0.00
NOPAT Less CapEx to Interest Expense
-0.49 -0.58 -3.07 -1.10 2.05 2.61 3.63 6.30 4.15 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% -38,488.88% 184.19% 113.46% 0.00% 0.00% 263.11% 9.40% 16.56%

Quarterly Metrics And Ratios for RH

This table displays calculated financial ratios and metrics derived from RH's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 1/28/2023 5/4/2024 8/3/2024 11/2/2024 2/3/2024 5/4/2024 8/2/2025 11/2/2024 2/1/2025 5/3/2025 8/1/2026
DEI Shares Outstanding
- - - - - - - - - - 18,900,969.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 18,900,969.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 3.18
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% -1.65% 3.64% 8.05% -49.16% -1.65% 12.33% 8.05% 10.04% 11.97% 11.15%
EBITDA Growth
0.00% -33.95% -28.17% 80.73% -69.67% -33.95% -9.99% 80.73% -0.68% 12.42% 19.24%
EBIT Growth
0.00% -46.44% -36.12% 120.86% -73.34% -46.44% -14.57% 120.86% -0.27% 11.34% 13.06%
NOPAT Growth
0.00% -46.74% -23.25% 123.20% -84.97% -46.74% -15.94% 123.20% -2.43% -108.19% -10.33%
Net Income Growth
0.00% -108.65% -62.14% 1,616.60% -83.26% -108.65% -32.39% 1,616.60% 22.28% 321.77% 107.82%
EPS Growth
0.00% -111.36% -56.85% 1,483.33% -79.87% -111.36% -22.02% 1,483.33% -21.98% 300.00% 111.03%
Operating Cash Flow Growth
0.00% -35.29% -93.08% -146.36% 90.08% -35.29% -93.08% -146.36% 83.53% 54.36% 893.89%
Free Cash Flow Firm Growth
0.00% 55.49% -2,171.33% -744.93% 0.00% -428.40% -631.23% -744.93% -75.48% -55.72% 117.73%
Invested Capital Growth
0.00% 16.63% 24.62% 35.75% 15.86% 16.63% 42.82% 35.75% 19.35% 18.94% -1.30%
Revenue Q/Q Growth
73.00% -34.42% 14.13% -2.16% -18.60% -1.53% 23.69% -2.16% 0.08% 0.19% 13.29%
EBITDA Q/Q Growth
503.62% -77.45% 53.04% 4.18% 1.29% -17.55% 91.77% 4.18% -24.45% -6.67% 56.51%
EBIT Q/Q Growth
824.82% -84.50% 80.92% 4.81% 11.66% -20.91% 141.97% 4.81% -33.50% -11.71% 83.72%
NOPAT Q/Q Growth
1,597.66% -93.52% 126.34% -7.57% 14.29% -66.40% 147.89% -7.57% 38.82% -102.82% 2,577.62%
Net Income Q/Q Growth
18,959.72% -100.99% 898.68% 14.56% 108.23% -131.85% 1,526.43% 14.56% -58.04% -42.24% 648.44%
EPS Q/Q Growth
12,516.67% -101.46% 825.00% 14.48% 80.72% -121.98% 1,410.00% 14.48% -57.23% -43.66% 665.00%
Operating Cash Flow Q/Q Growth
29.05% -17.05% -80.09% -381.29% 629.14% 149.26% -80.09% -381.29% 40.28% 561.49% 111.57%
Free Cash Flow Firm Q/Q Growth
100.00% 0.00% -32.45% -58.39% 65.97% -61.59% -154.08% -58.39% 48.24% -43.40% 130.08%
Invested Capital Q/Q Growth
1.87% 17.37% 5.06% 8.06% -13.05% 1.30% 20.41% 8.06% 3.77% 0.96% 0.33%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
57.24% 43.47% 45.17% 44.51% 50.98% 43.47% 45.52% 44.51% 44.66% 43.66% 48.24%
EBITDA Margin
34.55% 11.60% 15.55% 16.56% 20.61% 11.60% 17.98% 16.56% 12.50% 11.65% 16.69%
Operating Margin
32.34% 7.52% 11.59% 12.50% 17.22% 7.52% 14.33% 12.50% 8.66% 6.87% 11.67%
EBIT Margin
32.68% 7.36% 11.67% 12.50% 17.14% 7.36% 14.40% 12.50% 8.30% 7.32% 11.87%
Profit (Net Income) Margin
31.74% -0.50% 3.49% 4.09% 10.45% -0.50% 5.75% 4.09% 1.71% 0.99% 6.52%
Tax Burden Percent
146.85% 110.72% 77.15% 75.64% 77.96% 110.72% 71.73% 75.64% 132.72% 271.50% 102.96%
Interest Burden Percent
66.12% -6.12% 38.77% 43.23% 78.22% -6.12% 55.69% 43.23% 15.54% 4.97% 53.40%
Effective Tax Rate
-44.85% 0.00% 9.90% 21.11% 19.62% 0.00% 26.40% 21.11% -58.01% 105.61% 27.81%
Return on Invested Capital (ROIC)
102.66% 10.55% 20.68% 19.08% 23.71% 8.89% 16.70% 16.16% 20.90% -0.60% 13.16%
ROIC Less NNEP Spread (ROIC-NNEP)
79.66% 7.77% 17.91% 16.90% 22.24% 6.12% 14.67% 13.98% 16.69% -0.11% 12.39%
Return on Net Nonoperating Assets (RNNOA)
86.69% 42.76% -143.51% -141.06% 139.22% 33.66% -192.14% -116.69% -167.49% 1.30% -489.86%
Return on Equity (ROE)
189.35% 53.31% -122.83% -121.98% 162.94% 42.55% -175.45% -100.53% -146.59% 0.70% -476.69%
Cash Return on Invested Capital (CROIC)
0.00% 33.69% 27.16% 16.52% 2.49% 0.98% -20.38% -14.51% -2.99% -3.55% 0.82%
Operating Return on Assets (OROA)
22.10% 5.54% 9.80% 10.53% 10.99% 4.67% 10.07% 8.92% 6.07% 5.41% 8.98%
Return on Assets (ROA)
21.46% -0.38% 2.93% 3.44% 6.70% -0.32% 4.02% 2.92% 1.25% 0.73% 4.94%
Return on Common Equity (ROCE)
189.35% 53.31% -122.83% -121.98% 162.94% 42.55% -175.45% -100.53% -146.59% 0.70% -476.69%
Return on Equity Simple (ROE_SIMPLE)
0.00% -166.64% -185.59% -257.34% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
609 38 87 80 91 38 95 80 111 -3.13 78
NOPAT Margin
46.85% 5.26% 10.44% 9.86% 13.85% 5.26% 10.55% 9.86% 13.68% -0.39% 8.42%
Net Nonoperating Expense Percent (NNEP)
23.00% 2.77% 2.77% 2.18% 1.47% 2.77% 2.02% 2.18% 4.20% -0.48% 0.77%
Return On Investment Capital (ROIC_SIMPLE)
18.72% - - 3.34% 4.25% 1.78% 3.84% 3.34% 4.59% -0.13% 3.13%
Cost of Revenue to Revenue
42.76% 56.53% 54.83% 55.49% 49.02% 56.53% 54.48% 55.49% 55.34% 56.34% 51.76%
SG&A Expenses to Revenue
24.90% 35.95% 33.58% 32.01% 33.76% 35.95% 31.18% 32.01% 36.00% 36.79% 36.58%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
24.90% 35.95% 33.58% 32.01% 33.76% 35.95% 31.18% 32.01% 36.00% 36.79% 36.58%
Earnings before Interest and Taxes (EBIT)
425 53 97 101 113 53 129 101 67 60 109
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
449 84 129 134 136 84 162 134 102 95 154
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
9.35 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 26.00
Price to Tangible Book Value (P/TBV)
12.89 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.04 1.41 1.32 1.63 1.54 1.67 1.21 1.92 2.45 1.13 0.87
Price to Earnings (P/E)
13.88 10.43 10.91 12.67 36.57 61.40 65.66 85.38 107.67 43.79 19.65
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
7.21% 9.59% 9.17% 7.89% 2.73% 1.63% 1.52% 1.17% 0.93% 2.28% 5.09%
Enterprise Value to Invested Capital (EV/IC)
5.00 3.77 3.47 3.82 3.61 3.77 2.64 3.82 4.51 2.66 2.32
Enterprise Value to Revenue (EV/Rev)
2.28 2.03 1.94 2.27 2.26 2.40 1.96 2.68 3.22 1.86 1.47
Enterprise Value to EBITDA (EV/EBITDA)
9.86 9.21 9.51 10.46 13.85 16.46 14.47 18.51 22.76 13.22 9.16
Enterprise Value to EBIT (EV/EBIT)
11.34 10.73 11.28 12.32 18.80 22.76 20.63 26.09 32.04 18.69 12.28
Enterprise Value to NOPAT (EV/NOPAT)
9.39 8.28 7.84 9.38 22.57 24.86 20.88 27.78 33.52 20.99 18.64
Enterprise Value to Operating Cash Flow (EV/OCF)
20.29 19.44 31.47 67.53 401.32 42.25 289.03 0.00 598.19 127.70 35.89
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 12.05 14.17 26.60 155.53 414.89 0.00 0.00 0.00 0.00 280.24
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
3.14 -8.43 -10.50 -14.11 -8.23 -8.43 -61.44 -14.11 -15.81 -23.18 19.61
Long-Term Debt to Equity
3.14 -8.28 -10.32 -14.11 -8.09 -8.28 -61.44 -14.11 -15.81 -23.18 19.61
Financial Leverage
1.09 5.50 -8.01 -8.35 6.26 5.50 -13.10 -8.35 -10.03 -11.51 -39.54
Leverage Ratio
6.77 17.30 -16.54 -16.86 19.40 17.30 -27.37 -16.86 -18.87 -22.05 -83.13
Compound Leverage Factor
4.47 -1.06 -6.41 -7.29 15.17 -1.06 -15.25 -7.29 -2.93 -1.10 -44.39
Debt to Total Capital
75.87% 113.46% 110.53% 107.63% 113.83% 113.46% 101.65% 107.63% 106.75% 104.51% 95.15%
Short-Term Debt to Total Capital
0.05% 1.94% 1.88% 0.00% 1.95% 1.94% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
75.82% 111.52% 108.65% 107.63% 111.88% 111.52% 101.65% 107.63% 106.75% 104.51% 95.15%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
24.13% -13.46% -10.53% -7.63% -13.83% -13.46% -1.65% -7.63% -6.75% -4.51% 4.85%
Debt to EBITDA
2.97 3.10 3.34 3.24 4.94 5.55 5.94 5.74 5.76 5.58 4.08
Net Debt to EBITDA
1.03 2.81 3.06 2.97 4.43 5.02 5.58 5.26 5.41 5.22 3.75
Long-Term Debt to EBITDA
2.97 3.05 3.29 3.24 4.86 5.45 5.94 5.74 5.76 5.58 4.08
Debt to NOPAT
2.83 2.79 2.76 2.91 8.05 8.38 8.58 8.61 8.48 8.86 8.31
Net Debt to NOPAT
0.98 2.53 2.52 2.66 7.22 7.59 8.04 7.89 7.96 8.28 7.62
Long-Term Debt to NOPAT
2.83 2.74 2.71 2.91 7.92 8.23 8.58 8.61 8.48 8.86 8.31
Altman Z-Score
2.42 1.43 1.39 1.60 1.32 1.29 1.16 1.48 1.68 1.15 1.08
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.84 1.19 1.21 1.43 1.26 1.19 1.26 1.43 1.43 1.37 1.12
Quick Ratio
1.77 0.18 0.14 0.17 0.20 0.18 0.10 0.17 0.10 0.12 0.20
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -236 -313 -495 -168 -236 -599 -495 -256 -367 108
Operating Cash Flow to CapEx
209.36% 84.71% 22.77% -48.70% 185.95% 84.71% 22.77% -48.70% -36.89% 164.83% 343.96%
Free Cash Flow to Firm to Interest Expense
0.00 -4.16 -5.27 -8.59 0.00 0.00 0.00 -8.59 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
2.85 0.99 0.19 -0.55 0.00 0.00 0.00 -0.55 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
1.49 -0.18 -0.64 -1.67 0.00 0.00 0.00 -1.67 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.68 0.75 0.84 0.84 0.64 0.63 0.70 0.71 0.73 0.74 0.76
Accounts Receivable Turnover
60.08 58.17 59.58 61.62 52.76 49.04 53.86 52.19 53.66 51.63 49.34
Inventory Turnover
2.22 2.29 2.21 2.21 2.11 2.12 2.04 2.04 1.99 2.00 2.37
Fixed Asset Turnover
2.19 2.15 2.12 2.12 1.82 1.81 1.70 1.79 1.78 1.82 1.65
Accounts Payable Turnover
4.74 4.93 4.29 4.61 4.42 4.55 4.69 4.27 4.53 4.50 4.36
Days Sales Outstanding (DSO)
6.08 6.28 6.13 5.92 6.92 7.44 6.78 6.99 6.80 7.07 7.40
Days Inventory Outstanding (DIO)
164.56 159.22 164.84 165.50 173.14 172.50 178.88 178.71 183.32 182.15 153.72
Days Payable Outstanding (DPO)
76.95 74.03 85.00 79.12 82.51 80.20 77.90 85.44 80.61 81.09 83.63
Cash Conversion Cycle (CCC)
93.69 91.47 85.96 92.30 97.54 99.74 107.75 100.26 109.50 108.13 77.49
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,639 1,923 2,021 2,183 1,898 1,923 2,316 2,183 2,266 2,287 2,286
Invested Capital Turnover
2.19 2.00 1.98 1.93 1.71 1.69 1.58 1.64 1.53 1.55 1.56
Increase / (Decrease) in Invested Capital
0.00 274 399 575 260 274 694 575 367 364 -30
Enterprise Value (EV)
8,189 7,251 7,007 8,332 6,861 7,251 6,117 8,332 10,226 6,079 5,294
Market Capitalization
7,335 5,038 4,751 5,966 4,665 5,038 3,761 5,966 7,797 3,681 3,128
Book Value per Share
$33.23 ($15.83) ($12.73) ($9.90) ($16.32) ($15.83) ($2.18) ($9.90) ($8.79) ($5.91) $6.37
Tangible Book Value per Share
$24.10 ($27.68) ($24.50) ($21.67) ($28.23) ($27.68) ($14.11) ($21.67) ($20.46) ($17.66) ($5.50)
Total Capital
3,252 2,154 2,230 2,400 2,151 2,154 2,472 2,400 2,423 2,456 2,480
Total Debt
2,467 2,444 2,464 2,583 2,448 2,444 2,513 2,583 2,587 2,567 2,360
Total Long-Term Debt
2,465 2,402 2,422 2,583 2,406 2,402 2,513 2,583 2,587 2,567 2,360
Net Debt
854 2,213 2,255 2,366 2,196 2,213 2,357 2,366 2,429 2,398 2,165
Capital Expenditures (CapEx)
42 66 49 65 89 66 49 65 51 53 32
Debt-free, Cash-free Net Working Capital (DFCFNWC)
117 120 172 294 147 120 213 294 356 300 0.60
Debt-free Net Working Capital (DFNWC)
1,628 221 251 381 271 221 248 381 386 346 126
Net Working Capital (NWC)
1,627 180 209 381 229 180 248 381 386 346 126
Net Nonoperating Expense (NNE)
196 42 58 47 22 42 43 47 97 -11 17
Net Nonoperating Obligations (NNO)
854 2,213 2,255 2,366 2,196 2,213 2,357 2,366 2,429 2,398 2,165
Total Depreciation and Amortization (D&A)
24 31 32 33 23 31 32 33 34 35 44
Debt-free, Cash-free Net Working Capital to Revenue
3.25% 3.34% 4.78% 8.03% 4.86% 3.96% 6.84% 9.48% 11.19% 9.17% 0.02%
Debt-free Net Working Capital to Revenue
45.35% 6.19% 6.95% 10.40% 8.94% 7.34% 7.95% 12.28% 12.14% 10.58% 3.51%
Net Working Capital to Revenue
45.31% 5.02% 5.79% 10.40% 7.56% 5.95% 7.95% 12.28% 12.14% 10.58% 3.51%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$17.04 ($0.20) $1.57 $1.79 $3.26 ($0.20) $2.76 $1.79 $0.76 $0.43 $3.18
Adjusted Weighted Average Basic Shares Outstanding
23.52M 18.32M 18.46M 18.53M 19.88M 18.32M 18.74M 18.53M 18.49M 18.73M 18.91M
Adjusted Diluted Earnings per Share
$14.90 ($0.20) $1.45 $1.66 $3.00 ($0.20) $2.62 $1.66 $0.71 $0.40 $3.06
Adjusted Weighted Average Diluted Shares Outstanding
26.56M 18.32M 19.96M 19.98M 21.60M 18.32M 19.74M 19.98M 19.99M 19.91M 19.67M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
22.05M 18.45M 18.48M 18.60M 18.32M 18.45M 18.75M 18.60M 18.73M 18.73M 18.93M
Normalized Net Operating Profit after Tax (NOPAT)
294 38 87 80 91 38 95 80 49 39 78
Normalized NOPAT Margin
22.64% 5.26% 10.44% 9.86% 13.85% 5.26% 10.55% 9.86% 6.06% 4.81% 8.42%
Pre Tax Income Margin
21.61% -0.45% 4.52% 5.40% 13.41% -0.45% 8.02% 5.40% 1.29% 0.36% 6.34%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
13.84 0.94 1.63 1.76 0.00 0.00 0.00 1.76 0.00 0.00 0.00
NOPAT to Interest Expense
19.83 0.67 1.46 1.39 0.00 0.00 0.00 1.39 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
12.47 -0.22 0.81 0.64 0.00 0.00 0.00 0.64 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
18.47 -0.49 0.63 0.27 0.00 0.00 0.00 0.27 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
263.11% 0.00% 41.93% 31.85% 9.40% 0.00% 0.00% 17.16% 16.56% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

RH’s recent results show a meaningful recovery in revenue and profitability, but the balance sheet remains highly leveraged and cash-light. In Q3 2026, revenue reached $883.8 million, up 8.9% from $811.7 million in Q3 2025 and above the $751.2 million reported in Q3 2024. Net income increased to $36.3 million from $33.2 million year over year, while diluted EPS rose to $1.83 from $1.66. However, revenue declined sequentially from $899.2 million in Q2, and net income fell from $51.7 million.

Profitability has improved from the losses reported in Q3 2024 and Q1 2025, but margins remain below earlier levels. Q3 2026 gross margin was approximately 44.1%, compared with 44.5% a year earlier and 48.3% in Q3 2022. Operating income improved to $105.9 million, although the operating margin declined to roughly 12.0% from 12.5% year over year. Operating cash flow was positive in both Q1 and Q2 2026, totaling $224.3 million, but continued capital spending and debt repayments limited cash growth.

  • Revenue growth has returned: Q3 2026 revenue increased 8.9% year over year to $883.8 million, reversing the weaker revenue levels seen during 2023 through early 2025.
  • Net profitability remains positive: RH has generated positive net income in each reported quarter of 2026, following a $3.6 million loss in Q1 2025 and a $2.2 million loss in Q3 2024.
  • Operating cash flow improved substantially: Q1 and Q2 2026 operating cash flow totaled $224.3 million, compared with approximately $67.3 million in the comparable 2025 periods.
  • Share count has declined: Basic weighted-average shares fell to 18.8 million in Q3 2026 from 23.7 million in Q3 2022, which can support EPS growth when earnings improve.
  • Equity has recovered: Total common equity improved to $3.3 million in Q3 2026 from negative equity of $183.0 million in Q3 2025 and negative $333.2 million in Q3 2024.
  • RH continues to invest for expansion: Capital expenditures totaled $109.6 million in Q1 and Q2 2026, while acquisitions consumed another $35.6 million. These investments could support long-term growth, but their returns remain uncertain.
  • Working capital remains inventory-heavy: Inventory was $874.9 million at the end of Q3 2026, representing most of RH’s $1.12 billion in current assets. Investors should monitor inventory turnover and potential markdown risk.
  • Liquidity is limited: Cash and equivalents were only $43.1 million in Q3 2026, down sharply from $380.7 million in Q3 2024 and $2.15 billion in Q3 2022.
  • Leverage remains elevated: RH carried $2.44 billion of long-term debt and total liabilities of $4.79 billion in Q3 2026. Debt repayments exceeded new borrowings in both Q1 and Q2 2026, contributing to financing cash outflows.
  • Margins have compressed over the longer term: Gross margin declined from approximately 48.4% in Q3 2022 to 44.1% in Q3 2026, while interest-related costs and other expenses continue to materially reduce operating income before taxes.
09/13/26 09:27 PM ETAI Generated. May Contain Errors.

RH Financials - Frequently Asked Questions

According to the most recent income statement we have on file, RH's fiscal year ends in February. Their fiscal year 2025 ended on February 1, 2025.

RH's net income appears to be on an upward trend, with a most recent value of $72.41 million in 2025, falling from $91.00 million in 2014. The previous period was $127.56 million in 2024. Check out RH's forecast to explore projected trends and price targets.

RH's total operating income in 2025 was $322.59 million, based on the following breakdown:
  • Total Gross Profit: $1.41 billion
  • Total Operating Expenses: $1.09 billion

Over the last 10 years, RH's total revenue changed from $1.87 billion in 2014 to $3.18 billion in 2025, a change of 70.3%.

RH's total liabilities were at $4.78 billion at the end of 2025, a 7.5% increase from 2024, and a 480.1% increase since 2014.

In the past 10 years, RH's cash and equivalents has ranged from $5.80 million in 2018 to $2.18 billion in 2021, and is currently $41.19 million as of their latest financial filing in 2025.

Over the last 10 years, RH's book value per share changed from 17.76 in 2014 to -8.79 in 2025, a change of -149.5%.



Financial statements for NYSE:RH last updated on 9/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners